VT News
Lorrie Fair-Allen

Lorrie Fair-Allen

Ask VT AI
View News Summary
  • FDA issues draft guidance to streamline biosimilar approvals, aiming to cut bureaucracy and increase competition for lower-cost biologics.
  • Centene surprises with a Q3 profit, raises EPS guidance, and records a $6.7B impairment, sending shares higher despite broader market weakness.
  • Trump acknowledges 22nd Amendment but mulls workarounds, sparking debate over a potential third term.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • FDA issues draft guidance to streamline biosimilar approvals, aiming to cut bureaucracy and increase competition for lower-cost biologics.
  • Centene surprises with a Q3 profit, raises EPS guidance, and records a $6.7B impairment, sending shares higher despite broader market weakness.
  • Trump acknowledges 22nd Amendment but mulls workarounds, sparking debate over a potential third term.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Lorrie Fair-Allen

Top Topics

Trending in U.S.

World

Sport